Sunitinib malate 99%
4 Inquiries
341031-54-7
Industrial Grade
99%
SHANGHAI
20kg/Cardboard Drum
2020-11-26
Anti-tumor categories,Cardiovascular,Anti-Diabetes Class,4-(4-bromo-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one,4-Amino-3-chlorophenol hydrochloride,4-Amino-3-chlorophenol
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceSunitinib Malate (SU 11248 Malate) is a potent tyrosine kinase inhibitor targeting VEGFR2 and PDGFRβ with IC50s of 80 nM and 2 nM, respectively.Basic Info
-
Product Name:
Sunitinib malate
Other Name:Butanedioic acid,2-hydroxy-,(2S)-,compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);Butanedioic acid,hydroxy-,(2S)-,compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);1H-Pyrrole-3-carboxamide,N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-,(2S)-hydroxybutanedioate (1:1);Sunitinib malate;SU 011248;SU 11248;Sutent;Sunitinib L-malate;Sunitinib L-malate
CAS No.:341031-54-7
Molecular Formula:C22H27FN4O2.C4H6O5
Molecular Weight:532.566
Exact Mass:532.233337
EC Number:1308068-626-2
HScode:29337900
Categories:
Characteristics-
PSA:
172.06000
XLogP3:2.77040
Density:1.3600 g/mL at 25 °C(lit.)
Melting Point:189-191°C
Boiling Point:572.1ºC at 760mmHg
Flash Point:163 °F
Refractive Index:n20/D 1.455(lit.)
Water Solubility:DMSO: >10mg/mL
Storage Conditions:Store at +4°C
Hazard IdentificationClassification of the substance or mixture
Reproductive toxicity, Category 1B
Specific target organ toxicity â repeated exposure, Category 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H360 May damage fertility or the unborn child
H372 Causes damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Anti-tumor categories,Cardiovascular,Anti-Diabetes Class,4-(4-bromo-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one,4-Amino-3-chlorophenol hydrochloride,4-Amino-3-chlorophenol
-
Location:
No.9 Weidi Road-Jiangsu Life Science and Technology Innovation Park, Nanjing, P.R.C
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
7
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2008
-
Certifications:
business license
Nanjing CHICO Pharmaceutical Co., Ltd is a high-tech enterprise specializing in R&D, production and sales of APIs and pharmaceutical intermediates. We are recognized as National High-Tech Enterprises by Science and Technology Department of Jiangsu Province in 2014.Adhering to the "Consummate service Convincing honor" business strategy, CHICO will provide you the qualified products and first-class service which are based on our strong technical accumulation and outstanding professionalism.
CHICO was established in July 2008, our sales office and R&D center is located in No.9 Weidi Road -Jiangsu life science and Technology Innovation Park, covering an area of about 1800 square meters. Our GMP factory is located in AnQing--- AnQing CHICO pharmaceutical Co., LTD, with a total area of 20000 square meters. Meanwhile, we also have set our cooperative production base in Huai’an. Now we have a complete ,stable production chain of gram-kilogram-ton so that we can achieve rapid response in the whole R&D-scale up- producing process for new products at the first time.
We always regard the quality as life, thus we have established our quality department which is directly controlled by GM. Also we have set a perfect quality assurance system and strict quality control standards according to the GMP requirements' and we have already passed the ISO 9001 quality system certification.
We warmly thank the new and old customers that support and cooperate with us. We sincerely look forward to using "integrity, quality, efficient, professional" service to enhance mutual friendship and create brilliance hand in hand with you!
-
-
Inquiry History4 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Sunitinib Malate
50 G Aug 14, 2026 
India
Sunitinib Malate ( USP Grade )
50.00 KG Aug 23, 2024
United States
Sunitinib malate
50 G Aug 17, 2026 
Russia
Sunitinib Malate
1 KG Nov 28, 2024 Post an enquiry for this product